Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.078 AUD | -7.14% | -2.50% | -3.70% |
20/03 | Australia's Tax Agency Publishes Ruling on Invex Therapeutics' Capital Return | MT |
16/02 | Invex Therapeutics Narrows Fiscal H1 Loss on Lower R&D Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-3.70% | 3.87M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- IXC Stock
- News Invex Therapeutics Ltd
- Invex Therapeutics Secures Clearance for Phase 2 Neurological Trial in Germany; Shares Rise 4%